2 buy-rated ASX growth shares for investors this week

ResMed Inc. (ASX:RMD) and these ASX growth shares could be top options for investors this week. Here’s what you need to know about them…
The post 2 buy-rated ASX growth shares for investors this week appeared first on The Motley Fool Australia. –

Monadelphous share price rio tinto A small rocket take off from a laptop, indicating a share price surge

If you’re a growth investor, then you’re in luck. The local share market is home to a number of top companies that have the potential to grow strongly in the future.

Two top ASX growth shares that have been tipped as buys are listed below. Here’s why they are highly rated:

IDP Education Ltd (ASX: IEL)

IDP Education is a provider of international student placement and English language testing services. While it has been hit hard by the pandemic, it has been tipped to come out of the crisis in an even stronger market position. This could make it a big winner when trading conditions return to normal. Particularly given its investment in software, which appears to have given it another edge over the competition.

Last week analysts at Morgans put an add rating and $28.48 price target on the company’s shares. While the broker acknowledges that the awful COVID-19 outbreak in India is a headwind, it still believes the risk is to the upside for its earnings. This is due to pent-up demand and marger and acquisition opportunities.

ResMed Inc. (ASX: RMD)

Another growth share to look at is ResMed. This sleep treatment-focused medical device company has been growing at a solid rate for a decade. And thanks to its industry-leading products, growing software business, and the increasing awareness of sleep disorders, it looks well-placed to continue this trend over the next 10 years.

Particularly given its long runway for growth. Management estimates that there are ~1 billion people suffering from sleep apnoea worldwide, with only ~20% of these sufferers currently diagnosed. ResMed also appears well-placed to benefit from the shift to home healthcare thanks to its investments in the space.

Credit Suisse is a fan of ResMed. It recently put an outperform rating and $29.00 price target on its shares.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of February 15th 2021

More reading

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post 2 buy-rated ASX growth shares for investors this week appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!